2月12日，泰达生物(08189)盘中下跌8.05%，截至14:55，报0.4元/股，成交102.88万元。
天津泰达生物医学工程股份有限公司主要从事两大业务领域：生物复合肥业务，包括促进各种粮食和果蔬作物均衡生长的生物复合肥料产品；医疗健康产业，涉及养老服务、运营管理业务和脑波定量检测分析技术等。关键经营数据为公司注册资本1.89亿元人民币。
截至2024年中报，泰达生物营业总收入2.12亿元、净利润-412.32万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.